机译:高剂量大剂量氯吡格雷单次大剂量推注替罗非班在原发性冠状动脉成形术中的应用
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Dr. Siyami Ersek Thoracic and Cardiovascular Surgery Training and Research Hospital Cardiology Department Selimiye-Uskudar Istanbul Turkey;
Genlab Medical Diagnostic and Research Laboratory Goztepe-Kadikoy Istanbul Turkey;
Myocardial infarction; Primary percutaneous coronary intervention; Tirofiban; PFA-100;
机译:高剂量大剂量氯吡格雷的单次大剂量推注替罗非班在原发性冠状动脉血管成形术中。
机译:在经皮冠状动脉血运重建和支架置入过程中高剂量大剂量替罗非班与阿昔单抗和普通肝素对比伐卢定的随机对照研究(2比2):替罗非班对新型剂量与阿昔单抗联合氯吡格雷和凝血酶抑制的替罗非班评估(TENACITY)研究试验。
机译:西罗莫司洗脱支架对接受原发性经皮冠状动脉介入治疗的ST抬高型心肌梗死患者的长期结局具有性别特异性:从单中心大剂量Bolus替罗非班与西罗莫司洗脱支架或Bare-急性心肌梗死的金属支架研究试验
机译:在未受保护的左主冠状动脉闭塞的原发性血管成形术后立即结果
机译:血管成形术和缺氧对猪冠状动脉线粒体生物发生和内膜增生的影响
机译:替罗非班支持的初次经皮冠状动脉介入治疗对接受600 mg氯吡格雷治疗的患者的疗效和安全性:使用塞尔维亚STEMI注册临床中心进行倾向分析的结果
机译:急性ST段抬高型心肌梗死接受原发性经皮冠状动脉介入治疗的急性ST段抬高型心肌梗死患者使用SYNTAX评分预测1年临床结果急性心肌梗死)和多策略(急性心肌梗死研究中单一高剂量小肠替罗非班与阿昔单抗联合西罗莫司洗脱支架或裸金属支架的多中心评估)试验